Louis Chen
Stock Analyst at Scotiabank
(0.10)
# 4,424
Out of 5,072 analysts
10
Total ratings
20%
Success rate
-49.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Initiates: Sector Outperform | $140 | $125.84 | +11.25% | 1 | Nov 13, 2025 | |
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $2.35 | - | 8 | Sep 10, 2024 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $49.61 | +10.86% | 1 | Feb 24, 2022 |
Gilead Sciences
Nov 13, 2025
Initiates: Sector Outperform
Price Target: $140
Current: $125.84
Upside: +11.25%
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $2.35
Upside: -
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $49.61
Upside: +10.86%